arccheck® sunnuclear  (Sun Nuclear Corporation)

Journal: Medical Physics

Article Title: Feasibility of volumetric‐modulated arc therapy gating for cardiac radioablation using real‐time ECG signal acquisition and a dynamic phantom

doi: 10.1002/mp.17582

Figure Lengend Snippet: Comparison of VMAT dose distribution without gating (a) and with real‐time ECG synchronized gated delivery (b) measured with the SunNuclear ArcCHECK. Gamma analysis (c) and corresponding histogram of gamma values (d) are for 1% dose difference and 1 mm distance to agreement.

Article Snippet: Figure shows the comparison of the VMAT dose distribution measured with the SunNuclear ArcCHECK for the VT‐STAR plan delivered under non‐gated mode (a) and for the real time ECG‐synchronized gated delivery mode (b).

Techniques: Comparison

Journal: Journal of Applied Clinical Medical Physics

Article Title: Commissioning of Mobius3D/FX for patient‐specific quality assurance: The CUIMC—NewYork Presbyterian Hospital experience

doi: 10.1002/acm2.14183

Figure Lengend Snippet: Patient cases used for plan comparison between the ArcCheck measurements and MobiusFX dose calculations per linear accelerator. The left and right bars under each machine are representative of measurement and MFX gamma passing rates, respectively. The result indicates a large variation in the MFX gamma passing rates.

Article Snippet: Currently, our institute utilizes SunNuclear ArcCheck (SunNuclear Corporation, Melbourne, FL) for dose measurements.

Techniques: Comparison

Journal: Journal of Applied Clinical Medical Physics

Article Title: Analysis of patient‐specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology

doi: 10.1002/acm2.13219

Figure Lengend Snippet: QA platform (left) and QA platform with ArcCheck phantom (right).

Article Snippet: Prior to any treatment, the reference treatment plan was recalculated on the MR‐compatible SunNuclear ArcCheck (Melbourne, FL), measured and compared using a gamma criterion of 3%/2 mm with global normalization and a 10% low dose threshold.

Techniques:

Journal: Journal of Applied Clinical Medical Physics

Article Title: Analysis of patient‐specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology

doi: 10.1002/acm2.13219

Figure Lengend Snippet: ArcCheck phantom in the QA platform showing the directional components of each device.

Article Snippet: Prior to any treatment, the reference treatment plan was recalculated on the MR‐compatible SunNuclear ArcCheck (Melbourne, FL), measured and compared using a gamma criterion of 3%/2 mm with global normalization and a 10% low dose threshold.

Techniques:

Journal: Journal of Applied Clinical Medical Physics

Article Title: Analysis of patient‐specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology

doi: 10.1002/acm2.13219

Figure Lengend Snippet: Directional Tolerances for ArcCheck phantom and QA platform.

Article Snippet: Prior to any treatment, the reference treatment plan was recalculated on the MR‐compatible SunNuclear ArcCheck (Melbourne, FL), measured and compared using a gamma criterion of 3%/2 mm with global normalization and a 10% low dose threshold.

Techniques:

Journal: Journal of Applied Clinical Medical Physics

Article Title: Analysis of patient‐specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology

doi: 10.1002/acm2.13219

Figure Lengend Snippet: Total uncertainty of the ArcCheck phantom setup for the X and Y directions.

Article Snippet: Prior to any treatment, the reference treatment plan was recalculated on the MR‐compatible SunNuclear ArcCheck (Melbourne, FL), measured and compared using a gamma criterion of 3%/2 mm with global normalization and a 10% low dose threshold.

Techniques: